Randolph S. Marks - Concepedia

Author

Randolph S. Marks

Also Known As

A Herskovic, R Marks, R S Marks, R. MARKS, R. Marks, R. S. Marks, R.S Marks, R.S. Marks, RANDOLPH S. MARKS, Randolph Marks

156

Publications

8.2K

Citations

H-Index

102

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida WinnMed Missouri Valley Cancer Consortium

About

Randolph S. Marks is an author at Mayo Clinic specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	58	4.8K
2	Health Sciences	13	13	1.7K
3	Public Health	7	7	525
4	Natural Sciences	1	1	243
5	Allergy	1	1	95

Randolph S. Marks

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Screening for Lung Cancer with Low-Dose Spiral Computed Tomography Stephen J. Swensen, James R. Jett, Jeff A. Sloan, American Journal of Respiratory and Critical Care Medicine Computed TomographySurgical OncologyPathologyLung CancersOncology	2002	685
Clinical Features of 5,628 Primary Lung Cancer Patients Ping Yang, Mark S. Allen, Marie Christine Aubry, CHEST Journal MedicinePathologyClinical FeaturesPulmonary BlastomaOncology	2005	398
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer Scott M. Lippman, J. Jack Lee, Daniel D. Karp, JNCI Journal of the National Cancer Institute	2001	319
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 A. Visbal, Brent A. Williams, Francis C. Nichols, The Annals of Thoracic Surgery MedicineCancer ManagementEpidemiology Of CancerPathologyGender Differences	2004	279
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study Yafei Li, Chau‐Chyun Sheu, Yuanqing Ye, The Lancet Oncology Genome-wide Association StudyTobacco ControlGenetic VariantsAllelic VariantGenotype-phenotype Association	2010	251
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity. Alex A. Adjei, Charles Erlichman, J. Nathan Davis, PubMed Chemoprevention StrategyPathologyPharmacotherapyTumor BiologyTranslational Pharmacology	2000	243
Immunomodulatory treatment trial for paraneoplastic neurologicaldisorders Steven Vernino, Brian Patrick O’Neill, Randolph S. Marks, Neuro-Oncology	2004	214
Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer Alex A. Adjei, Ann M. Mauer, Laura M. Bruzek, Journal of Clinical Oncology	2003	213
Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma James A. Bonner, Jeff A. Sloan, Thomas G. Shanahan, Journal of Clinical Oncology	1999	208
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study Cheng E. Chee, Aneel A. Ashrani, Randolph S. Marks, Blood	2014	207

Page 1